The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer | Zendy

Yangming Chen | Zendy; Yujie Lei | Zendy; Jianbin Lin | Zendy; Yunchao Huang | Zendy; Jiguang Zhang | Zendy; Kai Chen | Zendy; Shihui Sun | Zendy; Xing Lin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

<p>The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer</p>

Author(s) -

Yangming Chen,

Yujie Lei,

Jianbin Lin,

Yunchao Huang,

Jiguang Zhang,

Kai Chen,

Shihui Sun,

Xing Lin

Publication year - 2020

Publication title -

oncotargets and therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.054

H-Index - 60

ISSN - 1178-6930

DOI - 10.2147/ott.s253730

Subject(s) - downregulation and upregulation , gene knockdown , cancer research , carcinogenesis , western blot , cell growth , lung cancer , apoptosis , reporter gene , biology , chemistry , cancer , gene expression , gene , medicine , oncology , genetics

Recently, long noncoding RNAs (lncRNAs) have been identified as novel and potential therapeutic targets in various cancer types. Nonetheless, the levels and biological effects of lncRNAs in non-small cell lung cancer (NSCLC) remain largely unknown. In this study, we aimed to identify the effects of lncRNA-LINC01260 throughout the progression of NSCLC and explore the underlying mechanism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research